Related Articles
Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas
CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer
RhoBTB2 gene in breast cancer is silenced by promoter methylation
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer
Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer